AdaptHealth (AHCO) Projected to Post Earnings on Tuesday

AdaptHealth (NASDAQ:AHCO) is expected to release its earnings data before the market opens on Tuesday, February 25th. Analysts expect AdaptHealth to post earnings of $0.25 per share and revenue of $829.19 million for the quarter. Persons interested in registering for the company’s earnings conference call can do so using this link.

AdaptHealth Trading Down 1.7 %

Shares of NASDAQ AHCO opened at $8.78 on Tuesday. The stock has a market capitalization of $1.18 billion, a P/E ratio of -5.32, a PEG ratio of 1.23 and a beta of 1.12. The stock’s 50 day moving average price is $9.93 and its two-hundred day moving average price is $10.25. The company has a quick ratio of 1.00, a current ratio of 1.24 and a debt-to-equity ratio of 1.34. AdaptHealth has a 52-week low of $7.01 and a 52-week high of $11.90.

Analysts Set New Price Targets

A number of research firms have commented on AHCO. Royal Bank of Canada decreased their price objective on shares of AdaptHealth from $13.00 to $11.00 and set an “outperform” rating for the company in a report on Tuesday, November 19th. Robert W. Baird lowered their price objective on shares of AdaptHealth from $16.00 to $14.00 and set an “outperform” rating for the company in a research report on Wednesday, November 6th. Canaccord Genuity Group cut their target price on shares of AdaptHealth from $14.00 to $13.00 and set a “buy” rating on the stock in a report on Wednesday, November 6th. UBS Group decreased their target price on AdaptHealth from $12.00 to $11.00 and set a “buy” rating for the company in a research note on Thursday, February 13th. Finally, Truist Financial dropped their price target on AdaptHealth from $13.00 to $12.00 and set a “buy” rating on the stock in a research report on Friday, November 15th. Five research analysts have rated the stock with a buy rating, According to data from MarketBeat, AdaptHealth presently has a consensus rating of “Buy” and a consensus price target of $12.20.

AdaptHealth Company Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.